Memantine for the Treatment of Alzheimer???s Disease

This publication has 27 references indexed in Scilit:

• A 24-week Randomized, Controlled Trial of Memantine in Patients With Moderate-to-severe Alzheimer Disease
  Alzheimer Disease & Associated Disorders, 2007
• Efficacy and safety of donepezil over 3 years: an open‐label, multicentre study in patients with Alzheimer's disease
  International Journal of Geriatric Psychiatry, 2007
• Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease
  The Primary Care Companion For CNS Disorders, 2006
• Memantine for dementia
  Cochrane Database of Systematic Reviews, 2006
• Long‐term efficacy and safety of galantamine in patients with mild‐to‐moderate Alzheimer's disease: multicenter trial
  European Journal of Neurology, 2004
• Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil
  JAMA, 2004
• A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)
  International Clinical Psychopharmacology, 2002
• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia
  Stroke, 2002
• The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones
  Neuropharmacology, 2001
• Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
  Neuropharmacology, 1999